A Randomized, Open Label Trial of Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified.

Trial Profile

A Randomized, Open Label Trial of Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Olanzapine (Primary) ; Lithium
  • Indications Bipolar depression; Bipolar II disorders; Depression
  • Focus Therapeutic Use
  • Acronyms OL study
  • Most Recent Events

    • 18 Jul 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2019.
    • 18 Jul 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Oct 2019.
    • 21 Mar 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top